Format
Sort by
Items per page

Send to

Choose Destination

Best matches for chitosan, obesity:

Search results

Items: 1 to 20 of 90

1.

Long-Term Treatment of Overweight and Obesity with Polyglucosamine (PG L112): Randomized Study Compared with Placebo in Subjects after Caloric Restriction.

Cornelli U, Belcaro G, Recchia M, D'Orazio N.

Curr Dev Nutr. 2017 Sep 22;1(10):e000919. doi: 10.3945/cdn.117.000919. eCollection 2017 Oct.

2.

Anti-Obesity Effect of Chitosan Oligosaccharide Capsules (COSCs) in Obese Rats by Ameliorating Leptin Resistance and Adipogenesis.

Pan H, Fu C, Huang L, Jiang Y, Deng X, Guo J, Su Z.

Mar Drugs. 2018 Jun 5;16(6). pii: E198. doi: 10.3390/md16060198.

3.

Recent developments in solid lipid nanoparticle and surface-modified solid lipid nanoparticle delivery systems for oral delivery of phyto-bioactive compounds in various chronic diseases.

Ganesan P, Ramalingam P, Karthivashan G, Ko YT, Choi DK.

Int J Nanomedicine. 2018 Mar 15;13:1569-1583. doi: 10.2147/IJN.S155593. eCollection 2018. Review.

4.

Improvement of Diet-induced Obesity by Ingestion of Mushroom Chitosan Prepared from Flammulina velutipes.

Miyazawa N, Yoshimoto H, Kurihara S, Hamaya T, Eguchi F.

J Oleo Sci. 2018 Feb 1;67(2):245-254. doi: 10.5650/jos.ess17159. Epub 2018 Jan 23.

5.

Development of antioxidant gliadin particle stabilized Pickering high internal phase emulsions (HIPEs) as oral delivery systems and the in vitro digestion fate.

Zhou FZ, Zeng T, Yin SW, Tang CH, Yuan DB, Yang XQ.

Food Funct. 2018 Feb 1;9(2):959-970. doi: 10.1039/c7fo01400g. Epub 2018 Jan 11.

PMID:
29322140
6.

The regulatory effects of fish oil and chitosan on hepatic lipogenic signals in high-fat diet-induced obese rats.

Chiu CY, Chang TC, Liu SH, Chiang MT.

J Food Drug Anal. 2017 Oct;25(4):919-930. doi: 10.1016/j.jfda.2016.11.015. Epub 2017 Feb 16.

7.

Hyaluronic Acid Coated Chitosan Nanoparticles Reduced the Immunogenicity of the Formed Protein Corona.

Almalik A, Benabdelkamel H, Masood A, Alanazi IO, Alradwan I, Majrashi MA, Alfadda AA, Alghamdi WM, Alrabiah H, Tirelli N, Alhasan AH.

Sci Rep. 2017 Sep 5;7(1):10542. doi: 10.1038/s41598-017-10836-7.

8.

In vitro inhibition of lipid accumulation induced by oleic acid and in vivo pharmacokinetics of chitosan microspheres (CTMS) and chitosan-capsaicin microspheres (CCMS).

Wu S, Pan H, Tan S, Ding C, Huang G, Liu G, Guo J, Su Z.

Food Nutr Res. 2017 Jun 14;61(1):1331658. doi: 10.1080/16546628.2017.1331658. eCollection 2017.

9.

Effect of Supplementation With Chitosan on Weight, Cardiometabolic, and Other Risk Indices in Wistar Rats Fed Normal and High-Fat/High-Cholesterol Diets Ad Libitum.

Bahijri SM, Alsheikh L, Ajabnoor G, Borai A.

Nutr Metab Insights. 2017 May 22;10:1178638817710666. doi: 10.1177/1178638817710666. eCollection 2017.

10.
11.
12.

Enhanced anti-obesity effects of complex of resistant starch and chitosan in high fat diet fed rats.

Si X, Strappe P, Blanchard C, Zhou Z.

Carbohydr Polym. 2017 Feb 10;157:834-841. doi: 10.1016/j.carbpol.2016.10.042. Epub 2016 Oct 17.

PMID:
27987997
13.

Hepatic and skeletal muscle mitochondrial toxicity of chitosan oligosaccharides of normal and diabetic rats.

Teodoro JS, Gomes AP, Varela AT, Duarte FV, Rolo AP, Palmeira CM.

Toxicol Mech Methods. 2016 Nov;26(9):650-657. Epub 2016 Oct 28.

PMID:
27790925
14.

Chitosan oligosaccharide: Biological activities and potential therapeutic applications.

Muanprasat C, Chatsudthipong V.

Pharmacol Ther. 2017 Feb;170:80-97. doi: 10.1016/j.pharmthera.2016.10.013. Epub 2016 Oct 20. Review.

PMID:
27773783
15.

Chitosan dosage regimen to trap fecal oil excretion after peroral lipase inhibitor administration in mice.

Jang Y, Je YT, Yun CW, Chung H.

Int J Biol Macromol. 2017 Jan;94(Pt A):484-491. doi: 10.1016/j.ijbiomac.2016.10.003. Epub 2016 Oct 13.

PMID:
27746355
16.

New Dietary Supplements for Obesity: What We Currently Know.

Ríos-Hoyo A, Gutiérrez-Salmeán G.

Curr Obes Rep. 2016 Jun;5(2):262-70. doi: 10.1007/s13679-016-0214-y. Review.

PMID:
27053066
17.

A single oral dose of a polyglucosamine influences the bioavailability of [9-(14)C]-Oleic acid in adult female Göttingen minipigs.

Cnubben NH, Tel SL, Hemmes MA, Langenkamp-Brand A, Grossouw D, Jansen HT, de Bie BT.

BMC Obes. 2016 Mar 15;3:18. doi: 10.1186/s40608-016-0096-2. eCollection 2016.

18.

Prawn Shell Chitosan Exhibits Anti-Obesogenic Potential through Alterations to Appetite, Affecting Feeding Behaviour and Satiety Signals In Vivo.

Egan ÁM, O'Doherty JV, Vigors S, Sweeney T.

PLoS One. 2016 Feb 22;11(2):e0149820. doi: 10.1371/journal.pone.0149820. eCollection 2016.

19.

Single-blind, placebo controlled randomised clinical study of chitosan for body weight reduction.

Trivedi VR, Satia MC, Deschamps A, Maquet V, Shah RB, Zinzuwadia PH, Trivedi JV.

Nutr J. 2016 Jan 8;15:3. doi: 10.1186/s12937-016-0122-8.

20.

Prawn Shell Chitosan Has Anti-Obesogenic Properties, Influencing Both Nutrient Digestibility and Microbial Populations in a Pig Model.

Egan ÁM, Sweeney T, Hayes M, O'Doherty JV.

PLoS One. 2015 Dec 4;10(12):e0144127. doi: 10.1371/journal.pone.0144127. eCollection 2015.

Supplemental Content

Loading ...
Support Center